Src Inhibitors Suppress the Growth of Papillary Thyroid Carcinoma

BACKGROUND: Papillary thyroid carcinoma is the most common thyroid malignancy. Most papillary thyroid carcinomas contain BRAF mutations or RET/PTC rearrangements, thus providing targets for biologic therapy. Our previous studies had suggested papillary thyroid carcinomas with a BRAF mutation and the...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Head Neck
Main Authors: Henderson, Ying C., Toro-Serra, Rafael, Chen, Yunyun, Ryu, Junsun, Frederick, Mitchell J., Zhou, Ge, Gallick, Gary E., Lai, Stephen Y., Clayman, Gary L.
Formato: Artigo
Idioma:Inglês
Publicado: 2013
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4401074/
https://ncbi.nlm.nih.gov/pubmed/23729178
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hed.23316
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares